Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07743788
NA

Efficacy, Satisfaction, and Safety of the Mesolipo® Protocol for the Treatment of Localized Adiposity

Sponsor: Antony de Paula Barbosa

View on ClinicalTrials.gov

Summary

This randomized, split-body clinical trial aims to evaluate the efficacy, safety, and participant satisfaction of the Mesolipo® protocol for the treatment of localized adiposity. Participants will receive the Mesolipo® intervention on one side of the body and an active comparator on the contralateral side. Outcomes will be assessed through standardized clinical, photographic, ultrasonographic, and patient-reported measures over a 90-day follow-up period to determine treatment effectiveness and safety.

Official title: Eficácia,Satisfação e Segurança do Protocolo Mesolipo® no Tratamento da Gordura Localizada: um Estudo Randomizado

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2025-01-01

Completion Date

2025-06-30

Last Updated

2026-08-04

Healthy Volunteers

No

Interventions

DRUG

Mesolipo®

Mesolipo® is an injectable formulation containing sodium deoxycholate administered by subcutaneous injection for the treatment of localized adiposity. The intervention is applied according to a standardized protocol regarding dose, injection technique, and treatment schedule.

DRUG

Pentoxifylline

Pentoxifylline diluted in saline solution administered by subcutaneous injection using the same injection technique and treatment schedule as the experimental intervention. This intervention serves as the active comparator.

Locations (1)

Instituto Antony Barbosa

Belo Horizonte, Minas Gerais, Brazil